Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

類似資料

• FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
  著者:: Griffiths, G, 等
  出版事項: (2009)
• Issues in data monitoring and interim analysis of trials.
  著者:: Grant, A, 等
  出版事項: (2005)
• CANparent trial evaluation: second interim report
  著者:: Cullen, M, 等
  出版事項: (2014)
• CANparent trial evaluation: First interim report
  著者:: Cullen, M, 等
  出版事項: (2013)
• Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial
  著者:: Masahide Oki, 等
  出版事項: (2024-12-01)